Videos

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • For physicians: VEGF tyrosine kinase inhibitor treatment risks
  • 2:08
  • Analysis suggests doctors and patients should take into account slightly elevated risk of fatal side effects in use of VEGF-tyrosine kinase inhibitor drugs sorafenib, sunitinib, and pazopanib.

Tags: TargetedTherapy